Table 1 Change in price and volume 2015/16 to 2018/19 for those antipsychotics with the greatest change in volume of prescribing
Actual Cost/DDD 2018/19 as % 2015/16 cost | Change in Total Prescriptions 2015/16 to 2018/19 | Number of Prescriptions 2018/19 | |
|---|---|---|---|
Quetiapine | 123% | 686,003 | 3,456,355 |
Olanzapine | 326% | 180,762 | 2,386,096 |
Risperidone | 140% | 68,435 | 1,720,600 |
Aripiprazole | 15% | 307,222 | 1,100,913 |
Amisulpride | 135% | 2424 | 393,944 |
Haloperidol | 386% | −15,159 | 331,199 |
Chlorpromazine | 1438% | − 68,179 | 264,164 |